The PDPK1-RSK2 axis as a potential convergent therapeutic vulnerability in B-cell lymphomas.
INTRODUCTION B-cell lymphomas (BCLs) are the most prevalent group of hematologic cancers, encompassing various subtypes, each with a distinct clinical course shaped by cell of origin, genetics, and etiology. Recent advances in subtype-specific immunochemotherapy, targeted therapies, and cellular immunotherapy have impr...